Literature DB >> 33103144

Perioperative Hypothermia after Transurethral Surgeries: Is it Necessary to Heat the Irrigation Fluids?

Evin Koleini1, Jared S Cohen2, Oussama M Darwish2, Leili Pourafkari1, Laura Rein3, Nader D Nader1.   

Abstract

OBJECTIVE: To investigate the role of heated irrigation fluids in the risk of hypothermia and related complications in patients undergoing transurethral procedures.
METHODS: The medical records of all patients who underwent transurethral procedures between 2000 and 2016 at the VA Hospital were reviewed. Irrigation fluids have been heated to 42°C since 2013, as per the institutional policy (Group II). Prior to this date, room temperature solutions were used (Group I). The perioperative body temperature, use of warming devices, procedure length, and anaesthesia type were extracted from records and compared for both groups. In addition, demographic and anthropometric data, preoperative comorbidities, laboratory data, admission information and postoperative complications were obtained from the quality improvement database.
RESULTS: There were 1,363 patients in Group I and 269 patients in Group II. Perioperative temperature was decreased by 0.10°C in Group I compared to a temperature gain of 0.32°C in Group II (p<0.001). Three hundred and forty-eight (21%) patients undergoing transurethral procedures developed hypothermia <36°C. There was no difference in the incidence of postoperative mortality or complications between the normothermic and hypothermic patients.
CONCLUSION: The replacement of room temperature solutions with warmed solutions for irrigation during transurethral procedures reduced the risk of temperature loss and hypothermia following these procedures. Available heating strategies effectively prevented the perioperative heat loss; however, such strategies did not affect the incidence of postoperative complications. © Copyright 2020 by Turkish Anaesthesiology and Intensive Care Society.

Entities:  

Keywords:  Complications; hypothermia; transurethral resection

Year:  2019        PMID: 33103144      PMCID: PMC7556645          DOI: 10.5152/TJAR.2019.61214

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


Introduction

Numerous studies have shown increased risk of postoperative complications, including infections, cardiac risks, coagulopathies and increased hospital stay in patients who had decreased body temperatures during the perioperative period (1). Suggested mechanisms of hypothermia-induced complications included the vasoconstriction of the blood vessels, impairing oxygen delivery through altered chemotaxis, and impairment of neutrophil and platelet function (2). For example, Schmeid et al. (2) showed a trend towards increased blood loss in patients experiencing mild hypothermia. Of note, patients undergoing endoscopic urology procedures were often aged >65 years and received irrigation fluids. Advanced age was shown to be a risk factor for perioperative hypothermia in several studies including a review performed by Blatteis et al. (3, 4) By studying patients undergoing transurethral procedures, Pit and Singh demonstrated the increased risk of a low body temperature with room temperature irrigation fluids (5, 6). However, only relatively recently after a growing body of literature showed increased risks associated with decreased body temperature perioperatively did it become standard in most hospitals to measure and maintain body temperature above 36°C intraoperatively (7, 8). Additionally, in many hospitals, protocols were only implemented if a patient’s body temperature fell below a specific temperature or if the length of procedure exceeded a set length of time (9). At the Veteran’s Affairs Western New York (VAWNY) Medical Center, strategies such as warming blankets and warmed intravenous fluids were implemented when a procedure was projected to last longer than 1 hour or if body temperature dropped below 36°C. However, implementation of warmed irrigation fluids instead of room temperature fluids became a standard of care towards the end of 2013 for all transurethral procedures. The goal of this study was to examine if hypothermia prevention strategies reduced the risk of decreased body temperature and the subsequent risk of postoperative complications. The primary endpoint of this study was the frequency of mild hypothermia as it was defined by body temperatures <36°C upon arrival of the patients at the postoperative anaesthesia care unit. We hypothesised that heated irrigation fluids would lower the incidence of hypothermia compared to those in whom unheated solutions were used and thereby decreasing postoperative complications.

Methods

A retrospective review of patient records consisting of 2,559 male patients who underwent endoscopic urology procedures between August 2000 and December 2016 was conducted using the Veterans Affairs Surgical Quality Improvement Program (VASQIP) database and computerised patient record system. Study design and protocol were reviewed by the institutional review board at the VAWNY Healthcare System (Buffalo) and were approved for their scientific and ethical merit. Due to its retrospective design, the study was exempted from obtaining informed consent form from each individual participant; however, extreme care was given to ensure patient privacy and confidentiality. A total of 2,559 urologic surgery procedures were performed. Four hundred and sixty anaesthesia records from 1998, 1999 and parts of 2000 were not available due to changes within the computerised record management protocol at the hospital. A total of 349 open surgical cases along with 118 cases <15 minutes in length were excluded from the data (Figure 1). Inclusion criteria for the study included all patients who underwent endoscopic urology procedures with the implementation of general or local anaesthesia methods along with either room temperature or heated irrigation fluids. Exclusion criteria included all surgical procedures that began or converted into open surgical procedures and procedures <15 minutes in length. Anaesthesia warming methods such as warming blankets and warmed intravenous fluids were recorded as well. In addition, anaesthesia computer records allowed for the collection of both postoperative and preoperative temperatures along with the intraoperative temperature trends and medications used during the case.
Figure 1

PRISMA flow diagram of the study

Prior to 2013, room temperature irrigation fluids were consistently used for transurethral procedures. Starting in January 2014 all patients received warmed irrigation fluids. These patients were separated into two groups and evaluated. Group I incorporated the use of room temperature irrigation fluids while Group II used heated irrigation fluids. Throughout both time periods, the anaesthesia department instituted warming blankets or warmed intravenous fluids if patient’s body temperature fell below 36°C or if cases went beyond 60 minutes. A multi-regression analysis was used to analyse the data. Primary endpoints included risk of hypothermia and a temperature drop below 36°C, while secondary endpoints included postoperative complications such as death, myocardial infarctions, cerebrovascular accidents, pulmonary embolus, infections, transfusion complications and returns to the operating room. If preoperative or postoperative temperature values were missing on the anaesthesia records, baseline temperatures (from the prior week preoperative visit) and PACU temperatures were implemented respectively. Samples were then analysed based on the groups that were normothermic or hypothermic at the end of the procedures to evaluate postoperative risk factors for comorbidities due to such temperature drops. The presence of a normal distribution was tested using the Kolmogorov–Smirnov test. Normally distributed data were represented as a mean±standard deviation, and variables that were not normally distributed were represented as a median (interquartile range). Data that were not normally distributed were analysed using the non-parametric Mann–Whitney U test for intergroup comparison. A sample size of 278 patients was calculated using the power analysis based on results of the incidence of hypothermia from another study (6), in which the overall incidence of hypothermia after the implementation of warmed irrigating fluids was 15%. To detect a drop in the rate of hypothermia to 10%, 232 patients with Type I error (an alpha error of 0.05) and a Type II error (a beta error of 0.2) were required. To account for potential losses, 269 patients were included within the warmed irrigation fluids group. A total of 1,369 patients had room temperature irrigation fluids used during surgery. Paired and unpaired t-tests were used to compare the mean temperatures for both normothermic and hypothermic patients with the incorporation of either heated or room temperature irrigation fluids. Chi-squared tests were implemented to evaluate categorical data, such as preoperative risk factors and postoperative outcomes secondary to temperature changes. A p-value <0.05 was determined as statistically significant.

Results

A total of 1,632 patients (median age, 71 years) underwent anaesthesia for endoscopic urology procedures between August 2000 and December of 2016 at the VAWNY hospital. Preoperative patient characteristics can be seen in Table 1, showing no significant differences between all groups; in addition, all patients included were found to be normothermic (with a temperature recording of at least 36°C) in the preoperative stage, without documented preoperative warming efforts. The median age within the normothermic group versus our hypothermia group was 72 (56–88) and 70 (57–83) years, respectively (p=0.114). There was no difference between the normothermic and hypothermic patients in body mass index (p=0.423) and body surface area (p=0.784). Haemoglobin A1C levels were on average 0.2% lower in the hypothermic patients, while fasting glucose levels were 5 mg dL−1 lower than in the normothermic patients (Table 2).
Table 1

Patient characteristic and the presence of comorbid conditions according to postoperative development of hypothermia with body temperature <36.0°C

Normothermia (n=1,382)Hypothermia (n=368)Odds Ratiop

ObservedExpectedObservedExpected[95% Confidence interval]

Hypertension830816.6204217.40.83 [0.66–1.04]0.109
Diabetes mellitus389375.987100.10.79 [0.61–1.03]0.084
Insulin injection8074.21419.80.64 [0.36–1.15]0.133
Oral hypoglycaemic drugs309301.77380.30.86 [0.65–1.14]0.298
benzodiazepines844877.9268234.11.70 [1.32–2.19]<0.001
Propofol12181216.2322323.80.94 [0.67–1.34]0.74
Inpatient status3813871091031.11 [0.86–1.42]0.436
Prior myocardial infarction2623.746.30.57 [0.20–1.65]0.297
Prior coronary revascularisation204197.44652.60.83 [0.59–1.16]0.271
Congestive heart failure4846.61112.40.86 [0.44–1.67]0.648
Prior cerebrovascular event183189.55750.51.20 [0.87–1.66]0.265
Chronic obstructive pulmonary diseases293294.68078.41.03 [0.78–1.37]0.823
Active smoking377375.999100.10.98 [0.76–1.27]0.885
Chronic kidney disease66.321.71.26 [0.25–6.24]0.782
Haemodialysis76.311.70.54 [0.07–4.36]0.553
Alcohol use6771.92419.11.37 [0.85–2.22]0.199
Peripheral vascular disease4341.1910.90.78 [0.38–1.62]0.504
Transfusion-related issues1010.332.71.13 [0.31–4.12]0.856
Previous sepsis53.901.10.79 [0.77–0.81]0.248
Emergent surgery1616.654.41.18 [0.43–3.23]0.753
Operating room time greater than 60 minutes383394.9117105.11.04 [0.99–1.10]0.124
Table 2

Laboratory values of the patients according to the status of hypothermia as defined by body temperature <36°C

Normothermia (n=1,382)Hypothermia (n=368)

PreoperativePostoperativePreoperativePostoperative

MedianIQRMedianIQRMedianIQRMedianIQRp

Haematocrit (percentage)40.66.635.16.441.35.935.25.20.055
White blood cell (count nL−1)7.22.910.55.77.12.69.94.40.975
Serum creatinine (mg dL−1)1.10.51.471.181.20.41.500.880.876
Prothrombin time (sec)12.91.812.54.60.166
Partial thromboplastin time (Sec)30.610.029.512.00.881
Serum sodium (mEq L−1)140313930.061
Potassium (mEq L−1)4.10.64.00.60.186
Blood glucose (mg dL−1)103451271050.053
Haemoglobin A1C7.61.86.90.90.022
Blood urea nitrogen (mg dL−1)20.39.021.913.00.032
Serum albumin (g dL−1)3.60.53.70.50.108
Serum bilirubin (mg dL−1)0.560.300.520.230.039
Serum alkaline phosphatase (IU L−1)924399620.065
Aspartate-glutamate transaminase (IU L−1)231621100.094

The top panel (measurements for haematocrit, white blood cell count and serum creatinine concentrations) were measured both before and after surgery, and analysis was performed with repeated measures. The p-values for these variables indicated the effect of hypothermia on the operative changes of these laboratory parameters. The remaining variables were measured only prior to surgery, and they were compared using independent t-tests

In terms of predicted risk of death within 30 days of surgery, the normothermic versus the hypothermic group had equal risks of death, both 0.97% (p=0.127). The risk of developing postoperative complications as predicted by the VASQIP model was not different in the normothermic and hypothermic patients (5.9%; p=0.930). Regardless of the trend in increasing the risk of death and perioperative complications, the actual frequency of all postoperative complications and mortality was similar between the hypothermic and the normothermic patients (Table 3). Cox regression model also demonstrated a similar hazard risk of death over an average of 140 months (follow-up period) for both normothermic and hypothermic patients regardless of heating the irrigation solutions (Figure 2).
Table 3

Adverse postoperative outcomes secondary to the development of hypothermia with body temperature <36.0°C

Normothermia (n=1,382)Hypothermia (n=368)Odds Ratiop

ObservedExpectedObservedExpected[95% Confidence interval]

Overall deaths470479.4137127.61.03 [0.98–1.09]0.249
Deaths within 30 days1011.142.91.11 [0.79–1.54]0.487
MACE-30a1919550.10 [0.81–1.23]0.981
Cardiac arrest33.210.81.05 [0.60–1.86]0.845
Troponin leak54.611.40.91 [0.64–1.31]0.676
Myocardial infarction43.911.10.99 [0.64–1.53]0.955
Cerebrovascular accident43.200.80.301
Renal failure76.111.90.87 [0.67–1.13]0.447
Acute kidney injury111114.53430.51.03 [0.94–1.14]0.455
Transfusion-related issue1010.332.71.13 [0.31–4.12]0.856
Return to the operating room9898.13130.91.01 [066–1.54]0.980
Other bleeding complications21.600.40.465
Haematocrit drop <3013813533360.98 [0.90–1.06]0.559
Failure-to-wean87.922.10.99 [0.72–1.35]0.936
Re-intubation55.521.51.11 [0.69–1.77]0.624
Wound infections33.210.81.05 [0.60–1.86]0.845
Urinary tract infections6670.32318.71.07 [0.94–1.21]0.253
Clostridium difficile infection44.721.31.19 [0.67–2.09]0.459
Systemic sepsis2221.355.70.97 [0.81–1.16]0.747
Organ-specific sepsis43.200.80.324
Outpatient pneumonia98.722.30.97 [0.73–1.28]0.816
New sepsis2322.555.50.98 [0.82–1.17]0.823
Pulmonary embolus11.610.41.58 [0.40–6.32]0.314
Deep venous thrombosis22.410.61.19 [0.53–2.64]0.601
PACU length of stay (min)108±62114±653.8 [−12.7–2.4]0.182
Total hospital length of stay (Day)7.5±18.85.0±22.72.5 [−1.5–6.5]0.225

Major adverse cardiac event within 30 days

Figure 2

Hazard function of postoperative hypothermia and normothermia over the study follow-up period

In Group I, 1,369 patients received room temperature irrigation fluids between 2000 and 2013, while 264 patients between 2014 and 2016 received heated irrigation fluids. There was a temperature loss of 0.10°C in Group I, while body temperature increased by 0.32°C in Group II in which patients were operated after the heated irrigating fluids protocol was implemented (p<0.001) (Figure 3a). Despite decreasing the risk of hypothermia, there was no difference in the frequency of postoperative complications between the two groups (Table 4). Similarly, patients in whom warming blankets were applied (n=479 total; n=332 in Group 1 and n=16 in Group 2) had increases in body temperature by 0.22°C, while those in whom warming blankets were not used (n=1,153), had a temperature loss of 0.14°C (p=0.015) (Figure 3b).
Figure 3. a, b

Changes in body temperature during the procedures (pre and post), comparing Group I and Group II for heating the irrigation fluids (a) and comparing the use of warming blanket (b)

Table 4

Adverse postoperative outcomes secondary to irrigation fluid temperature selected

Group I (n=1,363)Group II (n=269)Odds Ratiop

ObservedExpectedObservedExpected[95% Confidence interval]

Deaths within 30 days1010221.01 [0.22–4.65]>0.999
MACE-30a191823.50.53 [0.12–2.29]0.558
Cardiac arrest33.310.71.69 [0.19–16.3]0.514
Myocardial infarction6501>0.999
Stroke43.300.71.00 [0.99–1.01]>0.999
Temperature <36°C33229116570.20 [0.12–0.33]<0.001
Acute kidney injury12611815230.58 [0.33–1.01]0.057
Bleeding11.710.31.68 [0.42–6.71]0.303
Transfusion1311020.99 [0.98–1.00]0.144
Failure-to-wean78.431.61.20 [0.80–1.80]0.236
Re-intubation66110.98 [0.72–1.32]>0.999
Wound infections43.300.71.00 [0.99–1.01]>0.999
Urinary tract infections787410140.64 [0.33–1.25]0.236
C.diff infection45212.55 [0.46–14.0]0.259
Systemic sepsis2222440.92 [0.31–2.69]>0.999
Organ non-specific sepsis43.300.71.00 [0.99–1.01]>0.999
Outpatient pneumonia109120.51 [0.06–3.96]>0.999
New sepsis2321460.66 [0.23–1.94]0.631
Venous thromboembolism44.210.81.00 [0.99–1.01]>0.999

Major adverse cardiac cerebral event within 30 days

From all potential factors that may have led to development of hypothermia <36°C, a multivariate regression model revealed that the duration of operation was an independent factor that affected the changes in body temperature during transurethral procedures, with a rise in 0.002°C per minute of procedures (Table 5). In addition, it was discovered that the implementation protocols for heating irrigation fluids in Group II significantly reversed the perioperative heat loss when compared to Group I using room temperature fluids (p<0.001).
Table 5

Multivariate linear regression model in predicting the change in body temperature from its preoperative values

CoefficientStd. errorBetaT-ValuepLower boundUpper bound

Constant−0.5150.210−2.4500.014−0.928−0.103−0.515
Body surface area (M2)−0.1310.067−1.9570.051−0.2620.0001−0.131
Age (year)0.0020.0021.2440.214−0.0010.0050.002
Heating irrigation fluids0.4280.0479.126<0.0010.3360.5210.428
General anaesthesia0.0130.0550.2410.809−0.0940.1200.013
Duration of the procedure (minutes)0.0020.0014.485<0.0010.0010.0020.002

Discussion

Anaesthesia literature has shown that the management of core body temperatures is vital to limit iatrogenic outcomes in patients, especially in the hospital setting (2, 10). According to these findings, advanced age, length of procedure and implementation of room temperature irrigation fluids during endoscopic procedures each increased the risk of perioperative hypothermia (3, 5, 6). Numerous studies also showed that decreased body temperatures increased the risk of postoperative complications (2, 10). As a result, many investigators have suggested that protocols such as warmed irrigation fluids should be considered when managing patients in the operating room. Few studies have evaluated this specifically in urologic patients and related procedures (6). This study revealed that warmed irrigation fluids had a significant impact on the prevention of postoperative hypothermia, but failed to present any statistically significant changes in postoperative clinical outcomes. A randomised control trial by Pit et al. (5) found similar outcomes, though it exhibited a much smaller sample size (29 patients receiving warmed irrigation fluids) than this trial included (269 patients receiving warmed irrigation fluids. It is possible that the VA’s reactive warming strategies such as warming blankets, which were used both before and after 2014, were enough to prevent temperature decreases significantly enough to impact postoperative outcomes (8, 9). A longer procedure duration has been also shown to result in larger body temperature losses (9, 11). However, these studies implemented room temperature irrigation fluids, while our study sample was exposed to warmed irrigation fluids during the length of the procedures, possibly explaining the rise in temperature with increasing procedure length within our patient sample. Also, less than one-third of the transurethral procedures at our institution were >60 minutes. Similar to other studies which showed low complication risks associated with transurethral procedures (9, 12), this study demonstrated no differences in complications due to perioperative hypothermia. The overall complication risk remained non-significant despite the average patient age being >70 years, which has been shown to put patients at a greater risk during endoscopic surgeries (13). As a retrospective review, this study was also limited. One factor that cannot be underappreciated was the fact that the method of both postoperative and preoperative body temperature recordings was not always consistent or available within the anaesthesia or nursing record system. For example, the method and location of collection may have been different depending on whether postoperative temperature recording was taken by the PACU nurses or the anaesthesiologist in the operating room. Anaesthesiologists tend to use forehead temperature stickers, whereas PACU nurses often utilise oral temperature or forehead skin recordings from electronic thermometers (14, 15). The current literature suggests that skin surface temperatures are, on average, 2°C lower than core temperatures, indicating that such routes of body surface temperature procurement do not accurately reflect the patient’s core temperature (9). Temperature measurement recorded from the rectal route is still considered the closest reading reflecting the patient’s core body temperature, and all other routes are generally compared to the rectal temperature (14). In comparison, oral thermometry obtains more accurate data, and attaining temperatures are, on average, 0.25°C lower than core temperatures (15). Such discrepancies offer a major limitation in the standardisation procedures of this study. Although similar studies have evaluated the risk of hypothermia in within high-risk patients from the perspective of both anaesthesiologists and urologists, our study demonstrated a positive statistical effect with no clinical significance in terms of implementation of heated irrigation fluids when monitoring for postoperative complications (2, 15). Several studies have focused on the risks for specific medical complications due to the temperature drops during the perioperative period specifically in the urologic patient population; however, such results may have been influenced due to evaluating smaller sample sizes (1, 6). This trial further supports the previously identified hypotheses in the setting of a large sample size.

Conclusion

Rewarming strategies such as heated irrigation fluids effectively raise the body temperature and reduce the risk of developing perioperative hypothermia. Despite the reduced risk of hypothermia observed in patients who received warmed irrigation fluids, no change in postoperative complications within the urologic patient sample was observed. The relatively shorter duration of the transurethral procedures and lower overall risk of postoperative complications might have been the reasons for the benign findings related to hypothermia observed in this study. Heat-preserving policies that incorporate the use of warmed fluids for irrigation, especially in patients undergoing higher risk surgeries may be beneficial in decreasing unwanted events secondary to postoperative hypothermia.
  15 in total

Review 1.  Core temperature measurement: methods and current insights.

Authors:  Daniel S Moran; Liran Mendal
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

2.  New surgical thermal management guidelines.

Authors:  Daniel I Sessler
Journal:  Lancet       Date:  2009-09-26       Impact factor: 79.321

3.  Perioperative Temperature Measurement Considerations Relevant to Reporting Requirements for National Quality Programs Using Data From Anesthesia Information Management Systems.

Authors:  Richard H Epstein; Franklin Dexter; Ira S Hofer; Luis I Rodriguez; Eric S Schwenk; Joni M Maga; Bradley J Hindman
Journal:  Anesth Analg       Date:  2018-02       Impact factor: 5.108

4.  Unintended perioperative hypothermia.

Authors:  Stuart R Hart; Brianne Bordes; Jennifer Hart; Daniel Corsino; Donald Harmon
Journal:  Ochsner J       Date:  2011

Review 5.  Age-dependent changes in temperature regulation - a mini review.

Authors:  Clark M Blatteis
Journal:  Gerontology       Date:  2011-11-11       Impact factor: 5.140

6.  Isothermic irrigation during transurethral resection of the prostate: effects on peri-operative hypothermia, blood loss, resection time and patient satisfaction.

Authors:  M J Pit; R J Tegelaar; P L Venema
Journal:  Br J Urol       Date:  1996-07

Review 7.  Temperature monitoring and perioperative thermoregulation.

Authors:  Daniel I Sessler
Journal:  Anesthesiology       Date:  2008-08       Impact factor: 7.892

8.  Effect of irrigation fluid temperature on core temperature and hemodynamic changes in transurethral resection of prostate under spinal anesthesia.

Authors:  Rajeev Singh; Veena Asthana; Jagdish P Sharma; Shobha Lal
Journal:  Anesth Essays Res       Date:  2014 May-Aug

Review 9.  Prevention and Management Following Complications from Endourology Procedures.

Authors:  Jean Nicolas Cornu; Thomas Herrmann; Olivier Traxer; Brian Matlaga
Journal:  Eur Urol Focus       Date:  2016-04-13

Review 10.  Risk of acute myocardial infarction after transurethral resection of prostate in elderly.

Authors:  Claudio de Lucia; Grazia Daniela Femminella; Giuseppe Rengo; Antonio Ruffo; Valentina Parisi; Gennaro Pagano; Daniela Liccardo; Alessandro Cannavo; Paola Iacotucci; Klara Komici; Carmela Zincarelli; Carlo Rengo; Pasquale Perrone-Filardi; Dario Leosco; Fabrizio Iacono; Giuseppe Romeo; Bruno Amato; Nicola Ferrara
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

View more
  1 in total

1.  Implementation of multi-mode nursing insulation program for patients receiving surgery for spine tumor: a propensity score-matched analysis.

Authors:  Juan Liu; Chunyan Gao; Hailong Fu; Xiaonan Zhou; Li Zhang; Xiaomei Tang; Yanru Wu; Hui Zhu; Sisi Yang; Yafeng Qu; Yajuan Yang; Haiqin Yang
Journal:  BMC Surg       Date:  2022-01-08       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.